SEC 13F Intelligence

Waddell & Reed Financial Inc / ISI

Waddell & Reed Financial Inc’s Ionis Pharmaceuticals Inc Position

Does Waddell & Reed Financial Inc own Ionis Pharmaceuticals Inc (ISI)? Yes — 1.61M shares worth $73M (+0.15% of its 13F portfolio) as of Q1 2021, down from 2.15M shares the prior filed quarter.

Position Value
$73M
Q1 2021
Shares
1.61M
% of Portfolio
+0.15%
Quarters Held
10
currently held

Position History ISI

Reported value by quarter
Q4 ’18: $189MQ4 ’18Q1 ’19: $273MQ2 ’19: $204MQ2 ’19Q3 ’19: $191MQ4 ’19: $132MQ4 ’19Q1 ’20: $102MQ2 ’20: $128MQ2 ’20Q3 ’20: $102MQ4 ’20: $122MQ4 ’20Q1 ’21: $73Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20211.61M$73M+0.15%
Q4 20202.15M$122M+0.26%
Q3 20202.15M$102M+0.24%
Q2 20202.17M$128M+0.33%
Q1 20202.17M$102M+0.33%
Q4 20192.19M$132M+0.33%
Q3 20193.18M$191M+0.49%
Q2 20193.18M$204M+0.51%
Q1 20193.36M$273M+0.68%
Q4 20183.50M$189M+0.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Waddell & Reed Financial Inc’s full portfolio or all institutional holders of ISI.